Acute lymphoblastic leukemia: older patients and newer drugs.

@article{Larson2005AcuteLL,
  title={Acute lymphoblastic leukemia: older patients and newer drugs.},
  author={Richard A Larson},
  journal={Hematology. American Society of Hematology. Education Program},
  year={2005},
  pages={
          131-6
        }
}
Although the median age for adults with acute lymphoblastic leukemia (ALL) is older than 60 years, relatively few of these patients have been enrolled on prospective clinical trials. The presence of coexisting medical disorders and unfavorable cytogenetic and biological characteristics within this population presents considerable challenges for successful treatment using conventional chemotherapy programs. Selected patients have achieved remission and long-term survival following intensive… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

The modified hyperCVAD regimen in newly diagnosed adult acute lymphoblastic leukemia [abstract

  • DA Thomas, J Cortes, FJ Giles
  • (Suppl 1):590a
  • 2001
Highly Influential
6 Excerpts

Impact of age on the biology of acute leukemia

  • FR Appelbaum
  • American Society of Clinical Oncology Educational…
  • 2005

Similar Papers

Loading similar papers…